Avoidance of systemic anticoagulation during intermittent haemodialysis with heparin-grafted polyacrilonitrile membrane and citrate-enriched dialysate: a retrospective cohort study

Effects of Citrate Acid Concentrate (Citrasate®) on Heparin N Requirements and Hemodialysis Adequacy: A Multicenter, Prospective Noninferiority Trial

(2012) Jeffrey J. Sands et al.   BLOOD PURIFICATION

The Outcomes of Critically Ill Patients with Acute Kidney Injury Receiving Renal Replacement Therapy

(2011) Simon W. Lines et al.   INTERNATIONAL JOURNAL OF ARTIFICIAL ORGANS

Long-Term Citrate Anticoagulation in Chronic Hemodialysis Patients

(2011) Jakob Gubenšek et al.   THERAPEUTIC APHERESIS AND DIALYSIS

Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding

(2010) M. Kreuzer et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Increased Efficiency of Hemodialysis with Citrate Dialysate: A Prospective Controlled Study

(2009) R. J. Kossmann et al.   Clinical Journal of the American Society of Nephrology

Long-Term Outcomes of Acute Kidney Injury

(2008) Ryan Goldberg et al.   ADVANCES IN CHRONIC KIDNEY DISEASE

The clinical evaluation of low-dose heparin in haemodialysis: a prospective study using the heparin-coated AN69 ST membrane

(2007) J. Chanard et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION